Skip to main content
Clinical Trials/IRCT20210130050179N9
IRCT20210130050179N9
Recruiting
Phase 2

Clinical evaluation of the safety and effectiveness of the nanofiber undereye pad containing ketone enzyme to improve surface wrinkles and dark circles under the eyes compared to placebo

ano tarpak company0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ano tarpak company
Enrollment
10
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ano tarpak company

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 18\-59 years
  • Signed informed consent knowingly
  • The presence of mild to moderate periorbital wrinkle and darkness

Exclusion Criteria

  • Using any eye product within 2 weeks before the intervention
  • Strict diet in the period of 2 weeks before the intervention
  • Pregnancy or lactation
  • Being exposed to strong sunlight during the day

Outcomes

Primary Outcomes

Not specified

Similar Trials